| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -5,3 k € | -1.3% | -5,2 k € | +31.2% | -7,6 k € | -201.2% | 7,5 k € | -77.6% | 33,4 k € | -12.2% | 38,1 k € | +71.2% | 22,2 k € | -33.6% | 33,5 k € | -18.2% | 40,9 k € | +1.4% | 40,4 k € | -1.9% | 41,1 k € | -34.6% | 62,9 k € | -11.9% | 71,4 k € | -1.2% | 72,3 k € | +15.4% | 62,6 k € | -22.4% | 80,7 k € | -9.0% | 88,6 k € | +6.4% | 83,3 k € | |
| EBITDA | -5,8 k € | -1.5% | -5,7 k € | +27.9% | -8,0 k € | -239.3% | 5,7 k € | -82.7% | 33,1 k € | -12.2% | 37,7 k € | +72.6% | 21,8 k € | -33.6% | 32,8 k € | -18.4% | 40,2 k € | +1.3% | 39,7 k € | +16.0% | 34,2 k € | -26.5% | 46,5 k € | -14.1% | 54,2 k € | -3.9% | 56,4 k € | +18.8% | 47,5 k € | -24.6% | 62,9 k € | -14.0% | 73,2 k € | +22.7% | 59,7 k € | |
| Operating profit | -5,8 k € | -1.5% | -5,7 k € | +27.9% | -8,0 k € | -190.8% | 8,8 k € | -73.3% | 32,8 k € | -11.1% | 36,9 k € | +87.7% | 19,7 k € | -35.1% | 30,3 k € | +69.2% | 17,9 k € | +33.1% | 13,5 k € | +78.0% | 7,6 k € | -60.1% | 19,0 k € | -21.1% | 24,0 k € | +57.0% | 15,3 k € | +17.4% | 13,0 k € | -54.4% | 28,6 k € | -26.6% | 39,0 k € | +73.7% | 22,5 k € | |
| Profit/loss | -4,3 k € | -3.9% | -4,1 k € | +35.5% | -6,4 k € | -169.8% | 9,2 k € | -63.1% | 25,0 k € | -1.7% | 25,4 k € | +117.2% | 11,7 k € | -35.3% | 18,1 k € | +64.7% | 11,0 k € | +32.3% | 8,3 k € | +24.7% | 6,7 k € | -44.8% | 12,0 k € | -19.8% | 15,0 k € | +47.3% | 10,2 k € | +2.0% | 10,0 k € | +362.5% | 2,2 k € | -79.4% | 10,5 k € | +268.8% | 2,8 k € | |
| Equity | 165,7 k € | -2.5% | 170,0 k € | -2.4% | 174,2 k € | -3.6% | 180,6 k € | +9.3% | 165,2 k € | +17.8% | 140,2 k € | +22.1% | 114,8 k € | +11.3% | 103,1 k € | +21.2% | 85,1 k € | +14.8% | 74,1 k € | +12.6% | 65,8 k € | +11.2% | 59,1 k € | +25.6% | 47,1 k € | +23.7% | 38,1 k € | +36.6% | 27,9 k € | +55.9% | 17,9 k € | +13.8% | 15,7 k € | +3.1% | 15,2 k € | |
| Total assets | 167,5 k € | -2.6% | 172,0 k € | -5.3% | 181,6 k € | -1.6% | 184,5 k € | -2.8% | 189,9 k € | +7.9% | 176,1 k € | +21.7% | 144,6 k € | +6.9% | 135,3 k € | +12.8% | 119,9 k € | -13.4% | 138,4 k € | -32.7% | 205,8 k € | -9.6% | 227,7 k € | -11.7% | 258,0 k € | -7.2% | 278,1 k € | +2.5% | 271,3 k € | -13.8% | 314,5 k € | -14.6% | 368,2 k € | +0.2% | 367,4 k € | |
| Cash | 230,1 € | -93.2% | 3,4 k € | +126.1% | 1,5 k € | -96.3% | 40,4 k € | -70.8% | 138,1 k € | +42.6% | 96,9 k € | +29.1% | 75,1 k € | +31.8% | 57,0 k € | +17.2% | 48,6 k € | +3.9% | 46,8 k € | -42.7% | 81,6 k € | +11.2% | 73,4 k € | -13.2% | 84,6 k € | +18.8% | 71,2 k € | +186.6% | 24,8 k € | -62.8% | 66,7 k € | +5.2% | 63,4 k € | +24.1% | 51,1 k € | |
| Debts | 1,8 k € | -11.5% | 2,0 k € | -73.3% | 7,4 k € | +88.9% | 3,9 k € | -84.1% | 24,8 k € | -30.9% | 35,8 k € | +20.3% | 29,8 k € | -7.3% | 32,1 k € | -7.8% | 34,8 k € | -45.9% | 64,3 k € | -53.7% | 139,1 k € | -17.5% | 168,6 k € | -20.1% | 210,9 k € | -12.1% | 240,1 k € | -1.4% | 243,4 k € | -18.0% | 296,7 k € | -15.6% | 351,5 k € | -0.2% | 352,1 k € | |
| Staff | — | — | — | — | — | — | — | — | — | — | 0,1 | 0,2 | 0,2 | 0,2 | 0,2 | 0,3 | 0,4 | 0,3 | ||||||||||||||||||
Private limited company · Gent · incorporated on 05/11/2007
Private limited company loss-making in the latest fiscal year. Cash position declining (-93.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Apotheek De Smet F. is a Private limited company incorporated in 2007. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Gent.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette